SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on June 3, 2021, reporting events as of June 1, 2021. The registrant is incorporated in California and lists its common stock and warrants on the Nasdaq Capital Market. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding regulatory compliance and does not contain financial statements or performance metrics.
Material Changes
The primary material event is the resolution of a Nasdaq listing compliance issue. On January 4, 2021, the company was notified of non-compliance with Listing Rule 5620 regarding the annual meeting of shareholders. The company submitted a correction plan on February 18, 2021, and received an extension until May 30, 2021. On June 1, 2021, Nasdaq confirmed the company complied with the rule following the annual meeting held on May 28, 2021, closing the matter.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. The only risk addressed was the potential delisting due to failure to hold an annual meeting, which has been resolved. No unusual items or contingencies are disclosed in this text.
Key Facts for Investor Verification
- Confirm the registrant is Second Sight Medical Products, Inc., not Vivani Medical, Inc.
- Verify the company's continued listing status on the Nasdaq Capital Market following the June 1, 2021 compliance notice.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.
- Check the date of the next required annual shareholder meeting to ensure ongoing compliance with Listing Rule 5620.